Vivek Ramaswamy, endorsed by Donald Trump and Elon Musk, enters the Ohio gubernatorial race. Ramaswamy promises voters tax ...

The majority of the market isn't seeing the bigger picture for these stocks and their underlying companies. Big mistake.

Glenmark Pharmaceuticals will pay USD 7 million to settle lawsuits in the US related to generic drugs, including Zetia and ...

Glenmark Pharmaceuticals on Monday said it will pay USD 7 million to three entities to settle lawsuits in the US related to ...

Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

This year is the 50th anniversary of the role that put Lynda Carter on the map. From 1975 to 1979, she starred on TV as ...

Given that Merck hasn't made any major acquisitions since the Schering-Plough deal in 2009, we expect it will make a larger acquisition over the next two to three years. Beyond acquisitions ...

He began his career in drug discovery and development at Schering-Plough and GlaxoSmithKline, before moving on to Cerebricon and Almac Discovery. In his new role Rob will be responsible for bringing ...

and Merck–Schering-Plough ($41 billion). Taking this into account, the remaining spending of $34 billion represents a reduction of around 30% compared with 2008. From a strategic perspective ...